22 results
8-K
VERV
Verve Therapeutics Inc
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:06pm
or more series; (iv) establish a classified board of directors, divided into three classes, each of whose members will serve for staggered three-year
8-K
VERV
Verve Therapeutics Inc
13 Nov 23
Other Events
6:34am
bilirubin levels below the upper limit of normal. The increase in liver transaminases in the patient dosed in the 0.6 mg/kg cohort was classified
424B5
VERV
Verve Therapeutics Inc
29 Nov 23
Prospectus supplement for primary offering
4:47pm
in the patient dosed in the 0.6 mg/kg cohort was classified as a Grade 3 event. All infusion reactions and liver transaminase elevations resolved … a partnership or other entity or arrangement classified as a partnership for U.S. federal income tax purposes) of our common stock who is not for U.S
424B5
VERV
Verve Therapeutics Inc
28 Nov 23
Prospectus supplement for primary offering
4:25pm
in the patient dosed in the 0.6 mg/kg cohort was classified as a Grade 3 event. All infusion reactions and liver transaminase elevations resolved … a partnership or other entity or arrangement classified as a partnership for U.S. federal income tax purposes) of our common stock who is not for U.S
10-Q
2qdspa7
12 Aug 21
Quarterly report
8:53am
424B5
ihew4g63ed7yjyl08ps
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
v3vv8thpc4ck3ez
20 Jul 22
Prospectus supplement for primary offering
4:22pm
10-K
vk4ug8 x9o27kcclva
14 Mar 22
Annual report
7:04am
S-1
rlr 3j4pu7mj
28 May 21
IPO registration
4:04pm
424B4
i5o5a5m qd3nh9g251a9
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
bqo9 13r3k87wlc
14 Jun 21
IPO registration (amended)
6:15am